发明名称 INHIBITOR OF ASPARTYL PROTEASE
摘要 <P>PROBLEM TO BE SOLVED: To provide a new class of sulfonamides which are aspartyl protease inhibitors. Ž<P>SOLUTION: In one embodiment, this invention relates to a new class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl proteases using the compounds and methods for screening compounds for anti-HIV activity. Ž<P>COPYRIGHT: (C)2010,JPO&INPIT Ž
申请公布号 JP2010184932(A) 申请公布日期 2010.08.26
申请号 JP20100113714 申请日期 2010.05.17
申请人 VERTEX PHARMACEUT INC 发明人 MICHAEL R HALE;CHRISTOPHER T BAKER;STAMMERS TIMOTHY A;SHERRILL RONALD G;SPALTENSTEIN ANDREW;FURFINE ERIC S;MALTAIS FRANCOIS;ANDREWS III CLARENCE WEBSTER;MILLER JOHN F;SAMANO VICENTE
分类号 C07C311/29;C07D317/28;A61K9/20;A61K9/48;A61K31/27;A61K31/275;A61K31/277;A61K31/34;A61K31/341;A61K31/357;A61K31/36;A61K31/381;A61K31/40;A61K31/5377;A61K31/655;A61K31/662;A61K45/00;A61P31/14;A61P31/16;A61P31/18;A61P43/00;C07B53/00;C07C271/20;C07C271/22;C07C311/19;C07C311/42;C07C311/46;C07C317/06;C07C317/18;C07D307/20;C07D317/62;C07D319/06;C07D407/12;C07D409/12;C07D493/04;C07F9/09;C07F9/6561 主分类号 C07C311/29
代理机构 代理人
主权项
地址